Algorae Pharmaceuticals rises on distribution agreement with Dr Reddy's Laboratories
** Shares of Australia's Algorae Pharmaceuticals 1AI.AX rise as much as 15.4% to A$0.015, highest level since November 1, 2023 ** AI-enabled pharmaceutical co signs distribution agreement with Dr Reddy's Laboratories REDY.NS ** Agreement to supply chemotherapy medicine Capecitabine to Australian market ** About 10.6 mln shares change hands, 6.2x the 30-day average volume ** Stock has risen 150% this year, including session moves (Reporting by Roshan Thomas in Bengaluru) ((Roshan.Thomas@thomsonreuters.com;))
Recent news on Algorae Pharmaceuticals
See all newsBrief: Algorae Pharmaceuticals Executes License & Supply Agreement With Torrent Pharma
Brief: Algorae Pharmaceuticals And Zydus Enter Exclusive Commercial Agreement
Brief: Algorae Pharmaceuticals Raises A$3.9 Million At A$0.012 Per Share
Brief: Algorae Pharmaceuticals Says TGA Accepts Initial Registration Dossier For Evaluation
Brief: Algorae Pharmaceuticals Partners With Peter Maccallum Cancer Centre For Second AI-Driven Drug Synergy Screening Program